Related Experiment Video

Updated: Apr 26, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K

[Ageism and its clinical consequences in oncogeriatry: a review of existing data and intervention leads]

S Schroyen, S Adam, G Jerusalem

    Revue Medicale De Liege
    |July 29, 2014
    PubMed

    Insights

    Ageism, or age stigma, negatively impacts cancer care for older adults, leading to undertreatment and exclusion from clinical trials. This review explores ageism in oncogeriatrics and proposes interventions to mitigate its harmful effects.

    Area of Science:

    • Gerontology
    • Oncology
    • Social Sciences

    Context:

    • Aging population presents a growing challenge in oncology, with 70% of US cancer diagnoses projected for individuals over 65 by 2030.
    • Elderly patients are paradoxically underrepresented in clinical trials and receive suboptimal treatment compared to younger demographics.
    • Ageism, rooted in societal stereotypes about aging, emerges as a significant, yet often overlooked, factor contributing to discrimination in cancer care.

    Purpose:

    • To identify and analyze manifestations of ageism within the field of oncogeriatrics.
    • To examine the direct consequences of ageism on elderly cancer patients, healthcare professionals, and their interactions.
    • To explore potential intervention strategies to counteract the detrimental effects of ageism in oncogeriatric care.

    Summary:

    • This article investigates ageism in oncogeriatrics, highlighting how stereotypes about aging lead to discrimination against elderly cancer patients.
    • It details the negative impacts of ageism on patient treatment, clinical trial participation, and the patient-provider relationship.
    • The review incorporates research on typical aging processes to contextualize ageism's effects and proposes actionable interventions.

    Impact:

    • Increased awareness of ageism as a critical barrier in geriatric oncology.
    • Improved understanding of how age-based discrimination affects treatment outcomes and patient experiences.
    • Provides a framework for developing targeted interventions to promote equitable and effective cancer care for older adults.

    More Related Videos

    Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty07:27

    Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

    Published on: October 6, 2016

    12.2K
    Oral Health Assessment by Lay Personnel for Older Adults08:47

    Oral Health Assessment by Lay Personnel for Older Adults

    Published on: February 2, 2020

    12.4K

    Related Concept Videos

    Pharmacodynamics in Geriatric Patients: Effects of Age01:27

    Pharmacodynamics in Geriatric Patients: Effects of Age

    Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
    365
    Drug Dosing: Geriatric Patients01:15

    Drug Dosing: Geriatric Patients

    Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
    392
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

    Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
    393
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

    As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
    849
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

    Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
    377
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

    In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
    350